Marcia C Shearer

Title: Marcia C Shearer: Innovator in Antibiotic Development

Introduction

Marcia C Shearer is a prominent inventor based in Conshohocken, PA (US). She has made significant contributions to the field of antibiotic research, holding a total of 6 patents. Her work focuses on the development of novel antibiotic complexes that have the potential to combat bacterial infections.

Latest Patents

Among her latest patents is the invention of antibiotics produced by Kibdelosporangium aridum Shearer gen. nov., sp. This novel antibiotic complex, known as the AAD 216 complex, is derived from the cultivation of a fermentation broth containing Kibdelosporangium aridum Shearer gen. nov., sp. nov. ATCC 39323 microorganisms in an aqueous nutrient medium under submerged aerobic conditions. The AAD 216 complex, along with its major bioactive components—AAD 216A, AAD 216B, and AAD 216C—exhibits both antibiotic activity and growth promotant activity. Additionally, she has developed Kibdelosporangium aridum SK&F-AAD-609, a novel subspecies that produces AAD-216 antibiotics and AAD-609 antibiotics, which differ in the presence of glucosamine in the glycolipid radical instead of amino glucuronic acid.

Career Highlights

Marcia has worked with notable companies in the pharmaceutical industry, including SmithKline Beckman Corporation and SmithKline Corporation. Her innovative research has positioned her as a key figure in the development of new antibiotics.

Collaborations

Throughout her career, Marcia has collaborated with esteemed colleagues such as Joseph R Valenta and Betty A Bowie. These partnerships have contributed to her success in advancing antibiotic research.

Conclusion

Marcia C Shearer is a trailblazer in the field of antibiotic development, with a focus on innovative solutions to combat bacterial infections. Her contributions through her patents and collaborations highlight her significant impact on the pharmaceutical industry.